M C Fournie-Zaluski
Overview
Explore the profile of M C Fournie-Zaluski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
178
Citations
2071
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fournie-Zaluski M
Neurochem Int
. 2010 May;
12(3):375-82.
PMID: 20501241
The endogenous opioid peptides enkephalins are degraded in vitro by several metallopeptidases (aminopeptidases, enkephalinase, dipeptidylaminopeptidases). Selective and mixed inhibitors of these enzymes were obtained by a rational approach taking into...
2.
Noble F, Banisadr G, Jardinaud F, Popovici T, Lai-Kuen R, Chen H, et al.
Neuroscience
. 2001 Oct;
105(2):479-88.
PMID: 11672613
The selective and potent aminopeptidase N inhibitor [125I]RB 129 has been used for the radioautographic localization of this enzyme in rat brain, spinal cord and intestine. Brain microvessels and intestine...
3.
Chen H, Noble F, Roques B, Fournie-Zaluski M
J Med Chem
. 2001 Oct;
44(21):3523-30.
PMID: 11585456
Prodrugs of phosphinic dual inhibitors of the enkephalin degrading enzymes, neutral endopeptidase (NEP) and aminopeptidase N (APN), corresponding to the formula H(3)N(+)CH(R(1))P(O)(OR)CH(2)CH(CH(2)Bip)CONHCH(CH(3))COOCH(2)Ph, with R(1) = CH(3) or Ph and R...
4.
Nieto M, Wilson J, Walker J, Benavides J, Fournie-Zaluski M, Roques B, et al.
Neuropharmacology
. 2001 Sep;
41(4):496-506.
PMID: 11543770
The aim of this study was to investigate the facilitatory effects of subanalgesic or low doses of different drugs (acetylsalicylic acid, ibuprofen and morphine) on the antinociceptive responses induced by...
5.
Arbin V, Claperon N, Fournie-Zaluski M, Roques B, Peyroux J
Br J Pharmacol
. 2001 Jun;
133(4):495-502.
PMID: 11399666
The aim of this study was to determine whether acute dual angiotensin-converting enzyme (ACE)/neutral endopeptidase 24-11 (NEP) inhibition could improve whole body insulin-mediated glucose disposal (IMGD) more than ACE inhibition...
6.
Valverde O, Noble F, Beslot F, Dauge V, Fournie-Zaluski M, Roques B
Eur J Neurosci
. 2001 May;
13(9):1816-24.
PMID: 11359533
Recent studies have suggested that cannabinoids might initiate the consumption of other highly addictive substances, such as opiates. In this work, we show that acute administration of Delta9-tetrahydrocannabinol in mice...
7.
Meen M, Fournie-Zaluski M, Boucher M, Roques B, Eschalier A
Br J Pharmacol
. 2001 Apr;
133(1):179-85.
PMID: 11325808
1. RB 101, a complete inhibitor of enkephalin-catabolizing enzymes, has been previously shown to produce antinociception in normal rats after systemic administration. Moreover, its coadministration with a cholecystokinin-B (CCK-B) receptor...
8.
Reaux A, Fournie-Zaluski M, Llorens-Cortes C
Trends Endocrinol Metab
. 2001 Apr;
12(4):157-62.
PMID: 11295571
Among the main bioactive peptides of the brain renin-angiotensin system, angiotensin (Ang) II and AngIII exhibit the same affinity for type 1 and type 2 AngII receptors. Both peptides, injected...
9.
Chen H, Noble F, Mothe A, Meudal H, Coric P, DaNascimento S, et al.
J Med Chem
. 2001 Feb;
43(7):1398-408.
PMID: 10753476
The development of dual inhibitors of the two zinc metallopeptidases, neprilysin (neutral endopeptidase) and aminopeptidase N involved in the inactivation of the opioid peptides, enkephalins, represents an attractive physiological approach...
10.
Roques B, Anne C, Turcaud S, Fournie-Zaluski M
Biol Cell
. 2001 Jan;
92(6):445-7.
PMID: 11132706
No abstract available.